Investors reap the rewards of fast growing Bioventix

Bioventix (BVXP) describes itself as a specialist in “the creation and supply of sheep antibodies”. For the layman, sheep antibodies may sound like an unusual product. But for the group’s shareholders, they've proved a very lucrative investment.

To continue reading, subscribe today

and enjoy unlimited access to the following:

  • Tips of the Week
  • Funds coverage
  • Weekly features on big investment themes
  • Trading ideas
  • Comprehensive companies coverage
  • Economic analysis
Subscribe to Investors Chronicle

Related topics

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now